Zomedica公司是一家兽医保健公司,它报告2024年8月14日的财务结果。 Zomedica Corp., a veterinary health company, reports Q2 2024 financial results on Aug 14, 2024.
Zomedica公司是一家兽医保健公司,专门从事妇幼和随行动物的护理点诊断和治疗产品,将于2024年8月14日下午4时30分报告其2024年问题的财务结果。 Zomedica Corp., a veterinary health company specializing in point-of-care diagnostic and therapeutic products for equine and companion animals, will report its Q2 2024 financial results on August 14, 2024, at 4:30 p.m. ET的。 ET. 该公司在美国的可解决市场总额超过20亿美元,在20.23年将收入增长33%,达到2 500万美元,并保持9 100万美元的流动性。 The company, with a total addressable market in the U.S. exceeding $2 billion, posted a 33% revenue growth in 2023 to $25 million and maintains $91 million in liquidity. 其产品包括:脉冲电波系统、Assisi Loop治疗装置、TRUFORMA诊断平台、TRUVIEW数字细胞系统以及VetGuardian无触摸监测系统。 Its product offerings include the PulseVet shock wave system, Assisi Loop therapeutic devices, TRUFORMA diagnostic platform, TRUVIEW digital cytology system, and VetGuardian no-touch monitoring system.